Panel recommends new, better shingles shot over old version


Make text smaller Make text larger



Photos





By MIKE STOBBE

A federal panel is recommending that older people vaccinated for shingles get a new, better shot approved in October.

The advisory panel said the vaccine made by GlaxoSmithKline works better than the first one made by Merck, which has been sold in the U.S. since 2006. Health officials say many as 20 million Americans should get a second round.

Shingles, a painful blistery condition, occurs when the chickenpox virus resurfaces later in life. Merck's vaccine is recommended for people 60 and older. But health officials say its effectiveness drops sharply after about five years.

The Advisory Committee on Immunization Practices said doctors should first opt for Glaxo's Shingrix, licensed last week, which uses a new ingredient to boost its effectiveness. It was recommended for people 50 and older.



Make text smaller Make text larger

Comments

Pool Rules



MUST READ NEWS

Governor signs HVAC bill
Assemblyman Parker Space’s legislation bringing more highly skilled workers into the...
Read more »

Wirths calls for repeal of residency law
SPARTA — In response to a recommendation today that NJ Transit be exempt from the current residency law so it can hire trained engineers from out of state, Assemblyman Hal...
Read more »

Unemployment continues downward trend
Private-sector employment continued to expand in July while the state’s unemployment rate...
Read more »

Groups plan essay contest
The Sussex County Board of Chosen Freeholders, Department of Health and Human Services, Division of Senior Services and the Sussex...
Read more »

VIDEOS



Subscribe to our mailing list

* indicates required
Community Newspapers


MOST READ

Business & Real Estate
Lake house just listed
  • Aug 13, 2018
Columns
Journalists are not the Enemy
  • Aug 15, 2018
Local News
Governor signs HVAC bill
  • Aug 17, 2018

MOST COMMENTED



Find more about Weather in Lafayette, NJ